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Mitochondrial diseases produce profound neurological dysfunction via mutations affecting mitochon-
drial energy production, including the relatively common Leigh syndrome (LS). We recently described
an LS case caused by a pathogenic mutation in USMG5, encoding a small supernumerary subunit of
mitochondrial ATP synthase. This protein is integral for ATP synthase dimerization, and patient fibro-
blasts revealed an almost total loss of ATP synthase dimers. Here, we utilize in situ cryoelectron to-
mography (cryo-ET) in a clinical case-control study ofmitochondrial disease to directly studymitochon-
dria within cultured fibroblasts from a patient with LS and a healthy human control subject. Through
tomographic analysis of patient and control mitochondria, we find that loss of ATP synthase dimeriza-
tion due to the pathogenic mutation causes profound disturbances of mitochondrial crista ultrastruc-
ture. Overall, this work supports the crucial role of ATP synthase in regulating crista architecture in the
context of human disease.
INTRODUCTION
Mitochondrial diseases comprise a group of devastating neurological disorders caused by mutations
affecting mitochondrial energy production via oxidative phosphorylation (OxPhos). One of the most com-
mon OxPhos disorders is a neonatal- or pediatric-onset subacute necrotizing encephalomyelopathy
known as Leigh syndrome (LS) (Lake et al., 2015), which presents with progressive impairment in cognitive
and motor functions and premature mortality (Gerards et al., 2016). Of the over 75 unique pathogenic mu-
tations known to cause LS, most encode components of ATP generation (i.e., OxPhos) machinery,
including the four mitochondrial respiratory complexes, the ATP synthase, the electron carrier coenzyme
Q10, and the pyruvate dehydrogenase complex (Lake et al., 2016). More recently, LS and Leigh-like syn-
drome have been linked to pathogenic mutations in genes encoding proteins regulating crista architec-
ture, including SLC25A46 (Janer et al., 2016) and OPA1 (Finsterer and Zarrouk-Mahjoub, 2017). Indeed, LS-
causing mutations in SLC25A46 result in abnormal mitochondrial architecture, including significantly
shortened cristae (Janer et al., 2016), whereas disease mutations that reduce OPA1 expression produce
decreased mitochondrial volume density and diminished cristae membrane surface area (Zhao et al.,
2017).
We have recently described a case of relatively mild LS in a 7-year-old patient (henceforth ‘‘patient’’),
caused by a novel pathogenic mutation in the gene USMG5 (upregulated during skeletal muscle growth
protein 5) that encodes a small 6.5-kDa protein termed diabetes-associated protein in insulin-sensitive
tissues (DAPIT) (Barca et al., 2018). The mutation abolishes the canonical GT splice site donor of exon 4
and generates aberrant transcripts that are degraded via nonsense-mediated decay. Homozygosity results
in <10% of normal transcripts that persist due to leaky transcription (Barca et al., 2018). DAPIT is associated
with the mitochondrial respiratory complex V (ATP synthase) (Ohsakaya et al., 2011) as a supernumerary
rather than a structural subunit (Chen et al., 2007). Unlike other OxPhos subunits linked to LS, including
those within the ATP synthase, this protein has no known role in ATP production per se. Rather, it is thought
to localize to the transmembrane domain associated with the peripheral stalk that is required for ATP syn-
thase dimerization (Dudkina et al., 2010; Walker, 2013). Biochemical studies of the patient’s fibroblasts re-
vealed (1) no detectable ATP synthase dimers, (2) normal amounts of ATP synthase monomers, and (3)
decreased ATP synthase activity (Barca et al., 2018). Indeed, previously reported complete knockouts ofiScience 6, 83–91, August 31, 2018 ª 2018 The Author(s).
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the DAPIT protein exhibited40% decrease in ATP synthase enzymatic activity (Ohsakaya et al., 2011). ATP
synthase dimers are thought to play an important role in generating the curvature at the apex of mitochon-
drial cristae (Cogliati et al., 2016). Consistent with this, mutations that disrupt ATP synthase dimerization in
yeast cause crista ultrastructural defects in purified yeast mitochondria (Davies et al., 2012). Nevertheless,
the precise relationship between crista ultrastructure and ATP synthase dimerization defects in humans re-
mains poorly understood.
Abnormal crista ultrastructure has been correlated with dysfunctions in respiratory capacity, both in vitro (Niel-
sen et al., 2017) and in vivo in human skeletal muscle (Hackenbrock, 1966), and has been further linked to human
pathology (Acehan et al., 2007; Cogliati et al., 2016; Quintana-Cabrera et al., 2018). Disturbances in mitochon-
drial ultrastructure have also been characterized in patients with LS using conventional transmission electronmi-
croscopy (TEM) of biopsies (generally muscle) (Willems et al., 1977). Although the resolution of TEM data is suf-
ficient to distinguish suborganellar components including the mitochondrial outer membrane (MOM),
mitochondrial inner membrane (MIM), and cristae, the relatively harsh sample preparation can distort mem-
branes and causematerial loss (Mannella et al., 2013;Winey et al., 2014;Wisse et al., 2010), potentially obscuring
the interpretation of genuine biological phenotypes. The recent revolution in cryo-electron microscopy (cryo-
EM) has enabled the direct visualization of near-native samples without additional sample manipulations
such as chemical fixation (Pilhofer et al., 2010; Thompson et al., 2016). Further combination of cryo-EM with
tomographic imaging schemes in cryo-electron tomography (cryo-ET) enables three-dimensional visualization
of these specimens (McIntosh et al., 2005; Zick et al., 2009).
With few exceptions, to date, most high-resolution information on mitochondrial structure has been
obtained from cryo-ET analyses of purified organelles (Davies et al., 2012; Dudkina et al., 2010; Eng-
lmeier et al., 2017), leaving many questions open concerning the effects of disease on mitochondria
within the cellular context. While the thickness of biological samples has been a traditional limitation
of cryo-EM or cryo-ET imaging, the relatively thin morphology of primary human skin fibroblasts,
particularly in the periphery, provides an ideal intact biological environment to image cellular struc-
tures in situ. Moreover, mitochondria are spheroid or tubular/elongated structures 0.2–5 mm in diam-
eter (McCarron et al., 2013; Perkins and Frey, 2000) and are therefore amenable to imaging by cryo-EM
and cryo-ET without sectioning, provided that their surrounding environment is similarly thin (Davies
and Daum, 2013).
Here, we introduce the application of in situ cryo-ET to a clinical case-control study of a human mitochon-
drial disease. By utilizing cryo-ET to directly study mitochondria within cultured primary fibroblasts from a
patient with LS and a healthy human control subject, we found that a pathogenic mutation in DAPIT that
ablates ATP synthase dimerization causes profound disturbances of mitochondrial crista ultrastructure, re-
sulting in human disease.RESULTS
Cryo-ET Reveals Abnormal Architecture of Mitochondrial Cristae in Patient Cells
We first examined primary skin fibroblasts from a patient with LS and a healthy human control subject by live
confocal fluorescence light microscopy. We used the live mitochondrial marker MitoTracker Green FM and
saw no obvious differences in mitochondrial shape or distribution (Figures 1A and 1C).
Patient and healthy control fibroblasts were next grown on gold-carbon electronmicroscopy grids, vitrified, and
imaged within sufficiently thin regions of the cell (Figure S1). Tilt series were obtained from patient and control
mitochondria (n = 10 for each cell type) from at least three different biological replicates (i.e., independently
plunge-frozen cells). Visual inspection of the mitochondria within the individual micrographs from patient
and control cells revealed both spherical and tubular/elongated mitochondria, with closely apposed MIM
and MOM, and an electron-dense matrix containing cristae and calcium/phosphorus ion granules (Wolf
et al., 2017) (Figure S2). The appearance of these mitochondria was comparable to previous reports of in situ
human mitochondria (Hu, 2014) and consistent across both our patient and control samples. In addition, we
found that the signal-to-noise ratio is considerably lower for in situ datasets compared with prior work using pu-
rified mitochondria (Nicastro et al., 2000), as reflected in such parameters as mitochondrial matrix texture. We
therefore also analyzed isolatedmitochondria from control and patient fibroblasts. However, sincewe observed
changes in the crista organization compared with our in situ samples (data not shown), we decided to focus our
analyses on in situ data to maximize its biological relevance.84 iScience 6, 83–91, August 31, 2018
Figure 1. Analysis of Patient Mitochondria Reveals Abnormal Crista Membrane Architecture, Related to Figures
S1 and S2
(A and C) Representative fibroblasts from control and patient were stained with MitoTracker Green FM and imaged by live
confocal fluorescence microscopy at a magnification of 633, showing typical morphology of mitochondria. Scale bars
represent 5 mm.
(B and D) Control and patient mitochondria were imaged by in situ cryo-electron tomography at a nominal magnification
of 15,5003, and three-dimensional models of each organelle were generated by manual segmentation. Key
mitochondrial structural features are indicated, including: mitochondrial outer membrane (MOM), intracristal space (ICS),
mitochondrial inner membrane (MIM), and matrix granules (MG), with three-dimensional reconstructions at right. Scale
bars represent 200 nm.We next reconstructed each tilt series from patient and control mitochondria into three-dimensional vol-
umes (i.e., tomograms) with each tomogram representing an intact mitochondrion within its native environ-
ment (Figure S2, Videos S1, S2, S3, and S4). Of note, due to technical limitations inherent to cryo-ET, namely
the restriction of tilt series collection toG70, objects such as membranes perpendicular to the beam may
be poorly resolved (Leis, 2018). Thus, structures such as mitochondria can appear elliptically distorted at
their upper and lower margins. We therefore restricted our reconstructions to the middle regions of
each tomogram to ensure the accuracy of our analyses.
We further characterized the patient and control mitochondria using a series of standardized mitochondrial
measurements (Figure S3). No difference was observed in mitochondrial diameter (490 G 40 nm in patient
versus 580G 60 nm in control; p > 0.05; Figure S4A), cross-sectional area (1.633 105G 0.413 105 nm2 in patient
versus 1.593 105G 0.423 105 nm2 in control; p > 0.05; Figure S4B), or MIM-MOM distance (129G 18 A˚ in pa-
tient versus 138G 14 A˚ in the control; p > 0.05; Figure S4C), when comparing patient and control mitochondria.
As ATP synthase dimers have been implicated in the formation and maintenance of cristae (Davies et al.,
2012), we analyzed crista architecture. Inspection of mitochondria from both the control (Figures S2A–
S2J) and patient (Figures S2K–S2T) revealed a predominantly lamellar topology with tubular crista junctions
(Figure S2), consistent with previous descriptions (Mannella et al., 2013). However, the patient’s mitochon-
dria exhibited profound ultrastructural defects compared with those from the control, including bloated,
balloon-like cristae (Figures 1B, 1D, and S2K–S2T).
To characterize this abnormal morphology of patient mitochondria, we measured average crista lumen
width and crista apex angle (i.e., crista tip curvature) (Figures 2A and S3). We found that crista lumen width
was significantly increased in the patient (164 G 59 A˚ in patient versus 120 G 32 A˚ in healthy control; p <
0.0001), with a wider variation in values compared with control (250 A˚ range in patient versus 150 A˚ range
in control) (Figure 2B). In addition, previous studies of ATP synthase have localized dimers to crista tips,iScience 6, 83–91, August 31, 2018 85
Figure 2. Two-Dimensional Measurements of Patient Crista Architecture Reveal Increased Width and Blunted
Apex Curvature, Related to Figures S2–S4 and Videos S1, S2, S3, and S4
(A) Representative two-dimensional slices through cryoelectron tomograms, outlining cristae (white) for two-dimensional
measurement of crista lumen width at base, middle, and tip (inset; blue) and of crista apex angle (inset; red); scale bars
represent 200 nm.
(B) Quantitation of crista lumen width in A˚ for control (n = 41 cristae) and patient (n = 24 cristae); * indicates p < 0.0001.
(C) Quantitation of crista apex angle for control (n = 37 cristae) and patient (n = 12 cristae). Black bars denote averages.
For all graphs, significance was assessed by the Mann-Whitney test at 95% confidence. Data were collected from at least
three independent cells grown on three independent grids for both patient and control; * indicates p < 0.0001.
* indicates statistical significance.pointing to an important role in establishing the apex angle of curvature (Davies et al., 2011). We therefore
measured the apex angle in all cristae visible in these micrographs and found that patient cristae were
significantly blunted when compared with control cristae (105 G 12 angle of curvature in patient versus
78 G 8 in control; p < 0.0001; Figure 2C). Of note, crista junction width was conserved between patient
and control (261 G 45 A˚ in patient versus 290 G 77 A˚ in control; p > 0.05; Figure S4D), and values were
consistent with those previously reported (250–300 A˚) (Mannella et al., 2013; Quintana-Cabrera et al., 2018).
Three-Dimensional Analyses Reveal Diminished Total Cristae Volume in Patient Mitochondria
Visual inspection revealed a dearth of cristae within patient mitochondria compared with those of the healthy
human control (Figures 3A and S2; Videos S3 and S4), which we further characterized using three-dimensional
analyses. Visualization of mitochondrial cristae can depend greatly on biological factors (e.g., heterogeneous
distribution of cristae throughout a mitochondrion) as well as methodological factors, including the angle at
which themicrographwas recorded (e.g., difficulty in resolvingmembranes perpendicular to the axis of the elec-
tron beam in the reconstructed tomogram [Palmer and Lo¨we, 2014]). Therefore, quantitation of the total volume
of all cristae, relative to total mitochondrial volume, was performed using three-dimensional measurements
within reconstructed tomograms. Crista surface area relative to total volume occupied by all crista components
was significantly decreased in patient mitochondria compared with the control (0.98G 0.33 au in patient versus
1.29G 0.20 au in control; p = 0.03) (Figure 3B), providing further evidence that absence of ATP synthase dimer-
ization has profound effects on crista architecture. Importantly, we also found a significant decrease in total
cristae volume in patient versus control mitochondria (0.04G 0.03 au in patient versus 0.08G 0.03 au in control;
p = 0.02) (Figure 3C). Lastly, we measured the crista lamellarity (i.e., crista shape factor; defined as the surface
area of the crista membrane/crista lumen volume) (Csere´p et al., 2018) in patient and control mitochondria.86 iScience 6, 83–91, August 31, 2018
Figure 3. Three-Dimensional Analysis of Reconstructed Patient Mitochondria Reveals Abnormal Morphology and
Distribution of Cristae, Related to Videos S3 and S4
(A) Representative three-dimensional reconstruction of in situ mitochondria in tomograms from control and patient
fibroblasts. The latter demonstrate abnormally bloated cristae.
(B) Quantitation of the surface area-to-volume ratio of total cristae membrane (light green) surface area to intracristal
space (yellow) volume; * indicates p = 0.03.
(C) Quantitation of crista content, expressed as total cristae volume (membrane [light green in (A)] + intracristal space
[yellow in (A)]) per matrix volume [gray in (A)]; * indicates p = 0.02.
(D) Quantitation of crista lamellarity, expressed as the ratio of surface area of the crista membrane to the crista lumen
volume. In all calculations, we examined n = 10 mitochondria for control and n = 10 for patient; * indicates p = 0.02. For all
graphs, significance was tested by the Mann-Whitney test at 95% confidence. Data were collected from at least three
independent cells grown on three independent grids for both patient and control.
* indicates statistical significance.Consistent with our above-mentioned findings, crista lamellarity within patient mitochondria was significantly
diminished compared with control mitochondria (0.11 G 0.05 in patient versus 0.19 G 0.05 in control; p =
0.02) (Figure 3D).
DISCUSSION
Analysis of mitochondrial structure has long been integral to the understanding and diagnosis of human
OxPhos diseases like LS. Here, we apply in situ cryo-ET to a clinical case-control study of a humaniScience 6, 83–91, August 31, 2018 87
mitochondrial disease, enabling the three-dimensional study of near-native patient and healthy human
control samples without the significant preparation artifacts that have traditionally hindered such studies
in the past (Davies and Daum, 2013; Fo¨rster and Koster, 2017). In examining healthy human control mito-
chondria, we have now characterized the dominant crista architecture in primary human cells under near-
native conditions. These organelles are composed of tubular and lamellar cristae occupying a minority of
mitochondrial volume (Lea et al., 1994; Quintana-Cabrera et al., 2018). Notably, despite use of a direct elec-
tron detection camera, we remained limited in our ability to accurately resolve the individual ATP synthase
structures within our in situ dataset. We attributed this in part to the imaging parameters (e.g., defocus)
necessary for sufficient contrast to clearly identify mitochondrial morphology and ultrastructure within
the relatively thick intracellular regions examined. Therefore, rather than the angle inferred by direct visu-
alization of ATP synthases (in dimeric or monomeric forms), our angle measurements reflect the curvature
of the membrane itself at the crista tips. However, given that our value is similar to that seen in Polytomella
(attributable to a 70 dimer angle), we believe it is likely that the ATP synthase dimers themselves exhibit an
angle within the previously reported range (50 in Euglena gracilis [Muhleip et al., 2017], 65 in Trypano-
soma brucei [Muhleip et al., 2017], 86 in Saccharomyces cerevisiae [Davies et al., 2011], and 86 in Bos
taurus [Jiko et al., 2015]).
Our in situ cryo-ET analysis of the patient’s mitochondria provides strong evidence that maintenance of
crista architecture depends on ATP synthase dimerization and its absence produces profound ultrastruc-
tural defects, particularly in the setting of human OxPhos disease. The patient’s bloated cristae reflect
both an increased crista lumen width and an increased tip angle. This blunted curvature at the crista tips
(105 G 12 in the patient compared with 78 G 8 in the control) is consistent with a role for dimers in es-
tablishing high crista curvature, confirming earlier work in yeast (Davies et al., 2012). The decrease in total
cristae volume in the patient mitochondria also strongly supports the importance of ATP synthase dimer-
ization in forming cristae (Paumard et al., 2002). Because the patient’s mutation results in ‘‘leaky’’ expres-
sion of DAPIT, it is also likely that low amounts of residual protein are responsible for generating the few
cristae that are observed. Nevertheless, as crista junction widths were unchanged, it also remains possible
that ATP synthase dimers do not play a major role in regulating the formation of this structure. Indeed,
crista architecture can be influenced by extra-mitochondrial factors, including the organelle’s subcellular
localization and its interaction with other intracellular structures. However, our datasets of both patient
and control mitochondria included a comparable distribution of spheroid and tubular/elongated mito-
chondria that maintained a predominantly lamellar crista topology connected to the inner boundary mem-
brane by tubular crista junctions, in accordance with previous observations in fibroblasts (Lea et al., 1994;
Quintana-Cabrera et al., 2018). Because all mitochondria were imaged in comparable peripheral regions of
fibroblasts where the mitochondrial network was indistinguishable between patient and control (as deter-
mined by fluorescence microscopy), we consider it unlikely that the clinical phenotype associated with the
patient’s LS can be ascribed to differences in mitochondrial morphology influenced by other subcellular
factors, including those in the mitochondrial matrix.
Importantly, the work described here provides support for a unified pathogenic mechanism in LS by linking
the insufficient ATP production caused by an ATP synthase dimerization defect to structural defects in crista
architecture. We have recently come to appreciate the higher order organization of respiratory complexes,
which are concentrated within the cristae (Gilkerson et al., 2003) and arranged into multicomplex associa-
tions of predefined composition, including ATP synthase dimers (Allen et al., 1989; Althoff et al., 2011; Da-
vies et al., 2011; Gu et al., 2016; Schagger and Pfeiffer, 2000). Significantly, we recently showed that the pa-
tient’s mutation affected ATP synthesis in vivo by disrupting this ATP synthase dimerization, rather than by
interfering with ATP synthesis catalytic activity per se (Barca et al., 2018). Now, we implicate this disease-
causing mutation in a disruption of crista topology, which provides putative mechanisms by which the
dimerization defect might impair ATP synthesis (Figure 4). For example, highly curved cristae formed by
rows of ATP synthase dimers are thought to concentrate respiratory chain-derived protons, thereby maxi-
mizing the proton gradient (DpH) powering ATP synthesis (Strauss et al., 2008). By contrast, the patient’s
markedly abnormal cristae might concentrate protons less efficiently at crista tips, resulting in a lower
DpH and therefore a decreased protonmotive force. Also, the dimerization impairment might be impairing
crista formation, causing the patient’s comparatively cristae-deficient mitochondria’s lower respiratory ca-
pacity (Nielsen et al., 2017). It has been shown that ATP synthase interacts with components of the mito-
chondrial contact sites and cristae-organizing system (MICOS) machinery responsible for generating
cristae (Rampelt et al., 2017), and our results open the door for future studies to investigate the role of88 iScience 6, 83–91, August 31, 2018
Figure 4. Model of Patient Pathogenic Mutation
(A and B) Model representing crista architecture of mitochondria in fibroblasts from the (A) healthy control and (B) patient.
In mitochondria from the healthy human control, crista structure is regulated by several factors including MICOS (green),
OPA1 (blue), and ATP synthase (yellow). Protons (red) are concentrated at crista tips, as shown in the inset. By contrast, the
patient’s mitochondria demonstrate fewer cristae, as well as an increased crista tip angle of curvature and increased crista
lumen width. Crista junction width is unaffected. The pathogenic changes to the crista architecture may impair the
mitochondria’s capacity to concentrate protons efficiently at crista tips, resulting in a lower DpH and decreased
protonmotive force necessary to generate energy. Model adapted from Strauss et al. (2008) and Cogliati et al. (2016).DAPIT in this interaction. Overall, our findings highlight the role of mitochondrial ultrastructure in bioener-
getic output in vivo.
In the midst of the current cryo-EM revolution, maximum resolution continues to improve dramatically,
although to date much of the implementation of this technique has focused on highly purified samples.
Our application of in situ cryo-ET to human mitochondrial disease suggests the promise of a novel preci-
sion medicine-focused approach, where the study of pathogenic mutations in readily accessible and mini-
mally invasive patient samples may reveal important, yet subtle changes visible only under near-native
conditions.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.iScience 6, 83–91, August 31, 2018 89
SUPPLEMENTAL INFORMATION
Supplemental Information includes Transparent Methods, four figures, and four videos and can be found
with this article online at https://doi.org/10.1016/j.isci.2018.07.014.
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Figure S1. Imaging of mitochondria in fibroblasts grown on electron microscopy grids
5HODWHGWR)LJXUH. (A) Patient and control skin fibroblasts were grown directly on London 
finder grids. (B) Cells with thin, cryo-EM accessible regions (<500 nm) were identified. Within 
these regions, mitochondria were identified (C) and all mitochondria located over holes were 
imaged as in (D).
BA C D
Figure S2. Representative images of the entire dataset of in situ mitochondria from control 
and patient  fibroblasts 5elaWeG WR )LJXUe  anG )LJXUe 2. A slice taken from the 
center of each control (Panels A-J) and patient (Panels K-T) tomogram is shown, 
demonstrating the entire dataset of peripheral spherical and tubular/elongated mitochondria 
collected. Differences in overall crista architecture (crista paucity, bloated and blunted crista) were 
seen in patient mitochondria compared with those from the control. Scale bars = 200 nm. 
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Figure S3. Diagram of standardized mitochondrial measurements, Related to 
Figure 2. Mitochondrial components (black) and measurement parameters for 
characterizing crista Drchitecture (blue) are shown, along with respective 
previously described values.
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Figure S4. Mitochondrial size, MOM-MIM distance and crista junction width are 
unaffected by the USMG5 mutation in the patient 5elaWeG WR )LJXUe 2. (A) 
Quantitation of smallest mitochondrial diameter (defined as the diameter of 
spherical or width of tubular/ elongated mitochondria) in nm for control (n=8) and 
patient (n=9) mitochondria. Of note, two control and one patient mitochondria 
extended beyond the tomogram and size could not be determined. (B) Quantitation 
of mitochondrial cross-sectional area in nm2 for control (n=8) and patient (n=9) 
mitochondria. (C) Quantitation of the average MOM-to-MIM distance for control (n = 
10 mitochondria) and patient (n = 10 mitochondria); each point represents the 
average of four measurements (taken at four equally spaced points, corresponding 
approximately to 0°, 90°, 180°, and 270° positions). (D) Quantitation in Å of the 
cristae junction width for control (n = 18 crista junctions) and patient (n = 10 crista 
junctions). Significance tested by Welch’s t-test at 95% confidence. 
TRANSPARENT METHODS 
Cell Culture  
We obtained skin fibroblasts from the patient expressing a homozygous USMG5 
mutation (C.87+1G>C, 1 basepair after the end of Exon 3), and from a healthy human 
subject. All subjects provided written consent and all studies were performed in 
accordance with a Columbia University Medical Center (CUMC) IRB-approved protocol 
(#AAAJ8651). Skin biopsy to obtain the fibroblast cells was only performed following 
informed consent. The respective cells were cultured as previously described (Barca et 
al., 2018). Briefly, fibroblasts were cultured in Dulbecco’s minimal essential media 
(DMEM) (Thermo Fisher, Waltham, MA, USA) supplemented with 15% fetal bovine 
serum (FBS) (Sigma-Aldrich, St. Louis, MO, USA), 1% vitamin solution and 1% 
antibiotic-antimycotic (Thermo Fisher). All experiments were conducted on cells cultured 
for <15 passages.  
 
Confocal Fluorescence Microscopy  
For live fluorescence light microscopy, fibroblasts were plated 24 h prior to imaging in a 
35-mm uncoated glass-bottom culture dish (MatTek Corp., Ashland, MA, USA) at a 
density of ~30% coverage. Cells were stained with MitoTracker Green FM (Thermo 
Fisher) and imaged live on a Leica SP5 II laser scanning confocal microscope (Leica 
Camera AG, Wetzlar, Germany) using a 63x objective at the Confocal and Specialized 
Microscopy Shared Resource of the Herbert Irving Comprehensive Cancer Center at 
Columbia University.  
 
Cryo-electron tomography 
Sample preparation. Cells were plated for 24-48 h on fibronectin-coated Quantifoil R 
2/2 holey carbon Au 200-mesh or London Finder grids (Electron Microscopy Sciences, 
Hatfield, PA, USA) to a density of ~30% coverage and grown under normal culture 
conditions. Immediately prior to vitrification, BSA-coated 20-nm gold beads (Sigma-
Aldrich) were applied to grids as fiducial markers, and samples were then plunge-frozen 
in liquid ethane using a Vitrobot Mark IV (FEI Thermo Fisher, Hillsboro, OR, USA) with a 
blot force of 1 and a blot time of 8 sec using Whatman #1 filter paper at 100% humidity 
and 22°C.  
 
Cryo-electron tomography. Imaging was conducted on a Tecnai F30 Polara (FEI 
Thermo Fisher) microscope operating at 300 kV, with a Gatan K2 Summit direct 
electron detection (DED) camera (Gatan, Pleasanton, CA, USA) in super-resolution 
mode.  Images were collected using SerialEM (version 3; Boulder, CO, USA) 
(Mastronarde, 2005) and then binned down 2x to achieve a pixel size of 2.6 Å. Tilt 
series were collected using a bidirectional tilt scheme from 0°±60° with 1.5° increments 
and a defocus range of -5.0 to -6.0 µm. The cumulative total electron dose of each tilt 
series was 100-180 e-/Å2. Tilt series were subsequently aligned and reconstructed using 
the IMOD software package (version 4.9; Boulder, CO, USA) (Kremer et al., 1996). All 
identified mitochondria were imaged (11 patient and 18 gender-matched control 
mitochondria in total), and analysis was limited for both patient and control samples to 
the tilt series with highest signal-to-noise ratio (SNR) as determined by cross-
correlation-based alignment (n=10 for each group) using IMOD software. 
Representative data were collected from at least three independent cells grown on three 
independent grids for both patient and control samples.  
 
Ultrastructural characterization 
Ultrastructural characterization of mitochondria was performed using the Amira software 
package (Thermo Fisher FEI). All analyses were blinded to sample identity. 
Measurements were made according to the diagram shown in Fig. S3.  
 
Two-dimensional analyses. Two-dimensional analysis and quantitation were 
performed for each mitochondrion in a two-dimensional slice taken from the middle of 
the corresponding 3x-binned tomograms (8 pixels averaged together). All two-
dimensional quantitative measures were calculated using the Amira software package.  
Mitochondrial size was measured using two parameters: (1) along the shortest 
dimension, and (2) cross-sectional area. The crista apex angle was measured by 
placing a vertex at the extreme tip of a crista and connecting this to each crista 
membrane at the points where the membranes became most closely parallel. Crista 
width was measured by placing points directly opposite each other at the outer 
boundary of each of the two membranes comprising a crista and measuring the 
distance spanning the outer margins. For crista continuous with the inner boundary 
membrane (IBM), measurements were made near but not at the crista junction, which 
was measured separately. The distance between the MIM and MOM was measured for 
each mitochondrion by placing directly-apposed points on the MIM and MOM, as close 
as possible to the approximate 0°, 90°, 180°, and 270° positions. 
Three-dimensional analyses. Tomograms were aligned using the IMOD software 
package (Mastronarde and Held, 2017) (Videos S1 and S2), utilizing fiducial markers 
(whenever at least 5 fiducials were visible throughout a tilt series) or fiducial-free cross-
correlation. Three-dimensional volume reconstruction of 3x-binned tilt series was then 
conducted via a simultaneous iterative reconstruction technique (SIRT), using Tomo3D 
(Agulleiro and Fernandez, 2011). Volumes were subsequently rotated in IMOD to retain 
chirality while re-assigning the z-axis to that of the electron beam.  
 
Manual segmentation of mitochondrial membranes, as well as subsequent three-
dimensional modeling, quantitation, and video generation, were performed on 3x-binned 
tomograms using the Amira software package. To quantitate total cristae volume per 
mitochondrion, we determined the upper and lower boundary slices in the tomogram in 
which the entire MOM and adjacent IBM could faithfully be traced. Measurement was 
limited to the volume within these boundaries to ensure that total mitochondrial volume 
could be calculated and compared with crista volume; while all mitochondria were intact 
within their native environment, limitations inherent to TEM result in the upper and lower 
margins of each organelle from being visualized and this is the reason for the restriction 
of our measurements to segments where the entire boundary of the organelle could be 
determined. We then measured (1) the total volume within the IBM, including matrix and 
cristae (“mitochondrial volume”); and (2) the total volume occupied by all crista 
components, including crista membrane and intracristal space (“crista volume”). Cristae 
volume was divided by mitochondrial volume to calculate crista volume per 
mitochondrion. To quantitate crista surface-to-volume ratio, we subdivided the total 
crista volume into cristal membrane and intracristal space. To measure the crista 
lamellarity (i.e. crista shape factor), we divided the surface area of the crista membrane 
by the crista lumen volume as described previously (Cserep et al., 2018). 
 
Statistics 
Statistics was performed using GraphPad (version 6.0e for Macintosh; 
GraphPad Software, La Jolla, CA, USA). All datasets were tested for normality using the 
D'Agostino and Pearson omnibus normality test, with a<0.05 constituting a normal 
distribution. The crista width measurement dataset was found to have a non-normal 
distribution and was therefore analyzed for significance using the non-parametric Mann-
Whitney test, with p<0.05 defining a significant difference; crista lamellarity was similarly 
analyzed using the Mann-Whitney test. All other measurement datasets followed a 
Gaussian-like distribution and were analyzed using the parametric Welch’s t-test, with 
significance defined as p<0.05. 
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